Related Experiment Video

Updated: Aug 30, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Childhood vaccine development: an overview

Jeffrey P Baker1, Samuel L Katz

  • 1Department of Pediatrics, and Center for the Study of Medical Ethics and Humanities, Duke University Medical Center, Durham, NC 27710, U.SA. Baker009@mc.duke.edu

Pediatric Research
|November 25, 2003
PubMed

Insights

Pediatric vaccine development evolved in three phases throughout the 20th century, driven by advancements in bacterial and viral culture techniques. Continued innovation in vaccine research and development is crucial, despite challenges to collaboration.

Area of Science:

  • Pediatric research
  • Vaccinology
  • Immunization

Background:

  • The 20th century witnessed significant advancements in pediatric research, particularly in the development of vaccines for childhood diseases.
  • The U.S. immunization schedule is a product of evolving scientific understanding and technological capabilities.

Observation:

  • Vaccine development occurred in three distinct phases, influenced by breakthroughs in scientific methodologies.
  • Early 1900s: Bacterial culture techniques led to vaccines for diphtheria, tetanus, and pertussis.
  • 1950s onwards: Viral tissue culture enabled vaccines for polio, measles, mumps, rubella, and varicella.
  • Recent innovations: New technologies have yielded vaccines against hepatitis B, Haemophilus influenzae type b, and pneumococcus.

Findings:

  • Scientific breakthroughs, including bacterial and viral culture techniques, were primary drivers of vaccine innovation.
  • The development and implementation of vaccines involved collaboration across academic, private, and public sectors.
  • The historical trajectory of vaccine development highlights a continuous progression of scientific achievement.

Implications:

  • Understanding the history of vaccine development provides context for current challenges and future directions in pediatric research.
  • Maintaining collaborative networks is essential for the continued success of vaccine research and public health initiatives.
  • Factors threatening the fragmentation of collaborative networks could impede future vaccine innovation and accessibility.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...